Loading clinical trials...
Loading clinical trials...
Baseline Blood Indices as a Marker for Prolonged Length of Hospital Stay in Diabetic Older Patients With Mild or Moderate Covid-19 Infection
Conditions
Interventions
Inflamatory biomarkers
Locations
1
Turkey (Türkiye)
Gulhane training and research hospital
Ankara, Turkey (Türkiye)
Start Date
October 1, 2021
Primary Completion Date
November 1, 2021
Completion Date
December 1, 2021
Last Updated
September 23, 2021
NCT06959901
NCT06574035
NCT06861062
NCT07336329
NCT04583800
NCT06251323
Lead Sponsor
Gulhane Training and Research Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions